SPDL1 and lymphoma: In studies carried out in lymphoma patients, serum sPD-L1 levels significantly correlated with the expression of PD-L1 in lymphoma cells and patients with low sPD-L1 levels demonstrated a favorable clinical outcome (33, 34).